Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Skin Cancer01:30

Skin Cancer

6.5K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
6.5K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

3.4K
Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.4K
Metastasis02:30

Metastasis

6.8K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.8K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

6.3K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.3K
Abnormal Proliferation02:23

Abnormal Proliferation

5.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

15.4K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High-Risk Head and Neck Cutaneous Squamous Cell Carcinoma Treated with Mohs Micrographic Surgery: Low Actuarial Recurrence Rates Unless Multiple Major Risk Factors Present.

Journal of the American Academy of Dermatology·2026
Same author

Unintended consequences of legacy oversight in digital medicine.

Nature medicine·2026
Same author

Intravascular Squamous Cell Carcinoma Metastases Presenting Solely as Retiform Purpura: A Case Report.

Cureus·2026
Same author

Mark R. Wick, MD.

The American journal of surgical pathology·2026
Same author

Time Marches On.

The American journal of surgical pathology·2024
Same author

Tertiary lymphoid structures in desmoplastic melanoma have increased lymphocyte density, lymphocyte proliferation, and immune cross talk with tumor when compared to non-desmoplastic melanomas.

Oncoimmunology·2023

Related Experiment Video

Updated: Mar 19, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

16.7K

Spindle Cell Melanoma and Interdigitating Dendritic Cell Sarcoma: Do They Represent the Same Process?

Anne M Stowman1, Stacey E Mills, Mark R Wick

  • 1Department of Pathology, Division of Surgical Pathology, University of Virginia Health Sciences Center, Charlottesville, VA.

The American Journal of Surgical Pathology
|June 15, 2016
PubMed
Summary
This summary is machine-generated.

Diagnosing intranodal spindle cell lesions like spindle cell melanomas (SCM) and interdigitating dendritic cell sarcomas (IDCS) is challenging. Morphological and immunophenotypic features are nearly indistinguishable, suggesting a potential pathobiological similarity.

More Related Videos

Patient Derived Cell Culture and Isolation of CD133+ Putative Cancer Stem Cells from Melanoma
12:16

Patient Derived Cell Culture and Isolation of CD133+ Putative Cancer Stem Cells from Melanoma

Published on: March 13, 2013

21.9K
Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

9.7K

Related Experiment Videos

Last Updated: Mar 19, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

16.7K
Patient Derived Cell Culture and Isolation of CD133+ Putative Cancer Stem Cells from Melanoma
12:16

Patient Derived Cell Culture and Isolation of CD133+ Putative Cancer Stem Cells from Melanoma

Published on: March 13, 2013

21.9K
Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

9.7K

Area of Science:

  • Pathology
  • Oncology
  • Immunohistochemistry

Background:

  • Intranodal spindle cell lesions pose diagnostic challenges for pathologists.
  • Distinguishing between spindle cell melanomas (SCM) and interdigitating dendritic cell sarcomas (IDCS) is difficult due to overlapping features.
  • Current diagnostic methods, like electron microscopy, are often impractical.

Purpose of the Study:

  • To compare the immunophenotypes of SCM and IDCS.
  • To evaluate the expression of specific markers (MUM-1, β-catenin, SOX-10, MiTF, p75) in these lesions.
  • To determine if distinct immunophenotypic profiles can differentiate SCM from IDCS.

Main Methods:

  • Retrospective analysis of 18 SCM and 8 IDCS cases.
  • Comparative immunohistochemical evaluation using MUM-1, β-catenin, SOX-10, MiTF, and p75.
  • Review of relevant scientific literature.

Main Results:

  • Nearly equivalent staining patterns were observed for MUM-1, β-catenin, and p75 between SCM and IDCS.
  • SOX-10 showed strong nuclear reactivity in all cases of both entities.
  • MiTF expression varied (0% IDCS vs. 24% SCM), but overall profiles were highly similar.

Conclusions:

  • Morphologic and immunophenotypic features of SCM and IDCS are virtually indistinguishable.
  • The evaluated markers do not reliably differentiate between these two entities.
  • Further investigation is needed to clarify if SCM and IDCS represent a similar or identical pathobiological process.